Taiwan Chip Stocks Rally as Nvidias 150 Billion Spending Plan Fuels Sector Enthusiasm Investors Eye AMD Arm Marvell as Potential AI Chip Contenders Beyond Nvidia Foreign Portfolio Investors Voice Concerns Over Rupee Depreciation and Dwindling Returns at Hong Kong Conference Prediction Markets Surge in Popularity Attracting a Distinct Demographic Young Men AIDriven NBFCs Reshaping Indias Credit Landscape with Intelligent Lending Indian Equity Benchmarks Sensex and Nifty Turn Volatile Hindustan Zinc SBI Force Motors Lead Activity CCEP Q4 2018 Earnings Slight EPS Miss Highlights Cost Pressures ORIO Q1 2026 Earnings NarrowerThanExpected Loss Signals Improved Cost Discipline DRCT Q1 2026 Earnings NarrowerthanExpected Loss Signals Operational Resilience COGT Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline Health In Tech Inc HIT Q1 2026 Earnings Narrow Loss Beat Expectations Stock Dips 26 on Absent Revenue Details Adient ADNT Q1 2026 Earnings EPS Surprise Drives DoubleDigit Stock Rally MT Bank MTB Holds Steady Near 215 as Support and Resistance Levels Come into Focus Barings Participation Investors MPV Gains 146 Testing Key Resistance at 1805 Ibotta IBTA Gains Momentum Testing Key Resistance Level RF Acquisition Corp II RFAI Edges Higher SPAC Stock Nears Key Resistance Levels Chagee Holdings CHA Slides Over 4 as Bears Test Key Support Near 906 Amazons Potential Path to 20 Appreciation A Cautious Look at Key Drivers NMIH Q1 2026 Earnings EPS Beats Consensus by 18 Stock Slightly Lower Nuveen Churchill Direct Lending Corp NCDL Holds Steady Near Resistance Level EBAY Q1 2026 Earnings EPS Beats Estimates Modestly Stock Edges Higher PM Q1 2026 Earnings Earnings Beat Expectations Amid Solid Pricing Power SOWG Q3 2025 Earnings Massive EPS Miss Highlights Operational Headwinds TNXP Q1 2026 Earnings WiderThanExpected Loss Amid Continued Pipeline Development ALMS Q1 2026 Earnings EPS Beat Partially Offsets Investor Concerns Aqua Metals Q3 2025 Earnings EPS Misses Estimates by Wide Margin Amid Continued Operational Challenges BridgeBio Oncology Therapeutics Inc BBOT Q1 2026 Earnings NarrowerThanExpected Loss Fails to Stem Stock Slide